Phase 1 study of Safety and Immunogenicity of a Survivin Long Peptide Vaccine (SurVaxM)

Phase 1 study of Safety and Immunogenicity of a Survivin Long Peptide Vaccine (SurVaxM)

Lyer

Download The Abstract

Abstract

Download The Poster

Poster